- GE stock rockets after $21 billion deal with Danaher, but remains below key chart levelMarketWatch
- GE to sell BioPharma business to Danaher for $21.4BFox Business
- GE shares surge after Danaher agrees to buy biopharma business for $21.4 billionCNBC
- GE Deal With Danaher Shows Culp Is All About the Balance SheetBloomberg
- GE sells BioPharma business to CEO’s former company for $21.4 billionCNN
- View full coverage on Google News